Process for preparing 1-deoxy-1-methylamino-d-glucitol 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate
US2019175451A1
Particle size stabilization process
EP3347345A1
Mixed solvate of (r)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-1h-quinolin-2-one l-tartrate
EP2348013A1
Process for preparation of intermediates of arformoterol
WO2010012637A1
Process for the preparation of bosentan
EP2277866A1
Process for preparing telmisartan
EP2303877A1
Process to prepare paliperidone and intermediates thereof
EP2127641A1
Micronisable form of salmeterol xinafoate
EP2164848A1
Polymorphic form of granisetron base, methods for obtaining it and formulation containing it
EP2060557A1
Intermediate compounds useful to prepare dolasetron
EP2053043A1
Crystalline salt of montelukast
EP1975169A1
Process for the preparation of ziprasidone
EP2014649A1
Novel amorphous carvedilol dihydrogen phosphate
EP1849777A1
Process for obtaining a valsartan salt useful for obtaining valsartan
EP1958936A1
Process for obtaining montelukast
KR20080107359A
Method for preparing a mixed solvate of olanzapine
EP1904492A1
Method for obtaining the pharmaceutically active compound dolasetron, synthesis intermediates thereof and methods for obtaining them
ES2300175A1
PROCEDURE FOR OBTAINING USEFUL INTERMEDIATES IN OBTAINING A PHARMACEUTICALLY ACTIVE COMPOUND.
ES2292333A1
IMPROVEMENTS IN THE OBJECT OF THE MAIN PATENT N. 200401850, BY "MIXED SOLVATO OF OLANZAPINE, PROCEDURE FOR OBTAINING AND PROCEDURE FOR OBTAINING THE FORM I OF OLANZAPINE FROM THE SAME".
ES2288376A1
PROCEDURE FOR OBTAINING USEFUL INTERMEDIATES IN OBTAINING A PHARMACEUTICALLY ACTIVE COMPOUND.
